All lobbying filings
King & Spalding LLP
King & Spalding LLP filed a Q3 report for Egenesis Inc. on October 19, 2025, reporting no lobbying activity.
Lobbying for Egenesis Inc. · Gene editing platform for the development of transplantable organs.
Filing · LD-2 quarterly report
Q3 reportNo activity
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 19, 2025
Income
$80,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbying activity
0
No itemized activity in this filing.